Our Services
Medical Information
Helpful Resources
Published on: 7/2/2026
GLP-1 agonists (such as semaglutide and tirzepatide) can slow gallbladder emptying and, when paired with rapid weight loss, may raise the risk of gallstones — though most patients tolerate therapy without complications. A baseline ultrasound can be useful if you have a history of gallstones, plan significant weight loss, have abnormal liver tests, or carry other risk factors.
Key considerations include your personal risk category, the pros and cons of imaging, warning signs to watch for (such as upper right abdominal pain, nausea after fatty meals, or jaundice), and practical next steps to discuss with your provider.
Because gallbladder-related symptoms can mimic other digestive issues — and because GLP-1 side effects vary widely — it's worth clarifying what's actually behind your symptoms before deciding on imaging or treatment changes. Take a free, instant, online symptom check to better understand what's going on and confidently navigate your next steps.
Reviewed for medical accuracy: 07/02/2026
GLP-1 agonists—such as semaglutide, liraglutide and others—have transformed the management of type 2 diabetes and obesity. They help control blood sugar, curb appetite and drive weight loss. But as more people start GLP-1 therapy, questions arise about gallbladder health. Specifically, should you get a gallbladder scan before beginning GLP-1s?
This article explains:
No one-size-fits-all answer exists. Speak to a doctor about anything that could be serious or life-threatening.
GLP-1 (glucagon-like peptide-1) agonists work by:
These effects are great for weight loss and glucose control—but they can also:
Clinical trials report gallbladder-related side effects in about 1–3 percent of patients on GLP-1s. Most are gallstones (cholelithiasis), but some develop inflammation (cholecystitis).
Not everyone on GLP-1s needs a scan. You're at increased risk if you have:
If you tick any of these boxes, you may benefit from a baseline abdominal ultrasound—a noninvasive, painless way to check for existing stones or sludge.
Routine scanning before GLP-1 therapy isn't universally recommended. Instead, consider an ultrasound if you:
If you're in a lower-risk group with no symptoms, focus on education about warning signs and regular follow-up.
Monitor for these symptoms and seek medical attention if they occur:
If you experience severe abdominal pain or other concerning symptoms, use a free AI-powered Acute Cholecystitis symptom checker to quickly assess your condition and determine if immediate medical care is needed.
Discuss Your History with Your Doctor
Baseline Labs & Imaging
Educate Yourself and Your Support Team
Adjust Your Diet
Follow-Up Appointments
GLP-1 agonists offer proven benefits:
But gallbladder issues, while uncommon, can lead to:
Most patients tolerate GLP-1 therapy without serious gallbladder problems. By identifying those at higher risk and educating all users on warning signs, you can maximize benefits while minimizing surprises.
Always speak to a doctor about anything that could be life threatening or serious. Your healthcare team can help you weigh the pros and cons of a baseline gallbladder scan and guide you safely through GLP-1 therapy.
(References)
* pubmed.ncbi.nlm.nih.gov/35073801/
* pubmed.ncbi.nlm.nih.gov/36270685/
* pubmed.ncbi.nlm.nih.gov/28412030/
* pubmed.ncbi.nlm.nih.gov/35798226/
* pubmed.ncbi.nlm.nih.gov/36974797/
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.